Abnormal Expression of miRNAs in RCC
Download as PDF
DOI: 10.23977/fbb2020.024
Corresponding Author
Bixuan Wang
ABSTRACT
Renal cell carcinoma (RCC) is one of the most common malignant tumors of urinary system, accounting for about 3% of human malignant tumors, which is the tenth most common cancer in the world. However, there is a lack of accurate biomarkers for the diagnosis of RCC, and the mechanism of the occurrence and development of RCC is not clear. In recent years, many studies have focused on the abnormal expression of miRNAs in RCC. Studying the abnormal expression of miRNAs in RCC is helpful to understand the mechanism of occurrence and development of RCC, and to provide new ideas for the development of potential biomarkers and therapeutic targets of RCC.
KEYWORDS
Renal cell carcinoma, miRNAs, biomarkers